This course is for those professionals who want to add this type of service in their practices. Regulations on the application of botulinum toxin are not uniform for all states and countries and, because of this, the potential participant should review the current regulations in their areas. In Florida, only licensed MD, DO, NP and PA can administer these products.

Objective

Know the different types of botulinum toxin and its dilution. Understand the anatomy, the mechanism of formation of wrinkles and the therapeutic approach of them. Learn to differentiate static, dynamic wrinkles and correct patient selection. Manage and solve the most common complications associated with this type of procedure. Promote excellence and good practice in the field of Aesthetic Medicine, to practice professionally with scientific rigor, quality and effectiveness.

Each participant, after practicing in study models, will apply in real models the steps learned during the course, which include:

• The preparation of the medical-aesthetic record, the diagnosis, the selection of the points of application, the preparation of the product and the administration of botulinum toxin in the face of the client.
• At the end of the training, an examination and evaluation of the course will be carried out.
• The participant must reach at least 75% of the satisfactory answers to receive the Diploma that certifies their participation and knowledge about the use and application of botulinum toxin.

In the State Of Florida Only licensed MD, DO, NP and PA can administer these products.

• History of botulinum toxin.
• Types of botulinum toxin present in the market.
• Detailed anatomy of the upper third of the face and dangerous areas.
• Indications and contraindications of the procedure.
• Evaluation and selection of the patient.
• Review of the sterile technique in the application of botulinum toxin.
• Safety tips and how to avoid complications.
• Adverse reactions and their management.
• Live patient training, including diagnosis, treatment planning and adequate dose of botulinum toxin.
• Informed consent is necessary to begin treating patients immediately.
• Individualized and comprehensive training in model patients and hyperrealistic simulators.